trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Hsieh TH et al. Phthalates stimulate the epithelial to mesenchymal transition through an HDAC6-dependent mechanism in human breast epithelial stem cells. 2012 Toxicol. Sci. pmid:22552774
Vinken M et al. Trichostatin a enhances gap junctional intercellular communication in primary cultures of adult rat hepatocytes. 2006 Toxicol. Sci. pmid:16531468
Scholpa NE et al. Epigenetic changes in p21 expression in renal cells after exposure to bromate. 2014 Toxicol. Sci. pmid:25015661
Jergil M et al. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells. 2011 Toxicol. Sci. pmid:21427059
Wu Y et al. Regulatory Roles of Histone Deacetylases 1 and 2 in Pb-induced Neurotoxicity. 2018 Toxicol. Sci. pmid:29301062
Kang J et al. Nickel-induced histone hypoacetylation: the role of reactive oxygen species. 2003 Toxicol. Sci. pmid:12773760
Olaharski AJ et al. The histone deacetylase inhibitor trichostatin a has genotoxic effects in human lymphoblasts in vitro. 2006 Toxicol. Sci. pmid:16857700
Beedanagari SR et al. Differential regulation of the dioxin-induced Cyp1a1 and Cyp1b1 genes in mouse hepatoma and fibroblast cell lines. 2010 Toxicol. Lett. pmid:20116417
Nakajima M et al. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells. 2003 Toxicol. Lett. pmid:12927368
Liu Y et al. MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells. 2013 Toxicol. Lett. pmid:23770000
Vrzal R et al. Valproic acid augments vitamin D receptor-mediated induction of CYP24 by vitamin D3: a possible cause of valproic acid-induced osteomalacia? 2011 Toxicol. Lett. pmid:21115105
Bebenek IG et al. CYP2S1 is negatively regulated by corticosteroids in human cell lines. 2012 Toxicol. Lett. pmid:22155357
Singh RD et al. Arsenic exposure causes epigenetic dysregulation of IL-8 expression leading to proneoplastic changes in kidney cells. 2015 Toxicol. Lett. pmid:26008221
Xia B et al. Chromium(VI) causes down regulation of biotinidase in human bronchial epithelial cells by modifications of histone acetylation. 2011 Toxicol. Lett. pmid:21641978
Gao A et al. Methylation of PARP-1 promoter involved in the regulation of benzene-induced decrease of PARP-1 mRNA expression. 2010 Toxicol. Lett. pmid:20230882
Henkens T et al. Differential effects of hydroxamate histone deacetylase inhibitors on cellular functionality and gap junctions in primary cultures of mitogen-stimulated hepatocytes. 2008 Toxicol. Lett. pmid:18358644
Wu TC et al. Genistein enhances the effect of trichostatin A on inhibition of A549 cell growth by increasing expression of TNF receptor-1. 2012 Toxicol. Appl. Pharmacol. pmid:22626855
Luo SF et al. Activation of ROS/NF-kappaB and Ca2+/CaM kinase II are necessary for VCAM-1 induction in IL-1beta-treated human tracheal smooth muscle cells. 2009 Toxicol. Appl. Pharmacol. pmid:19281832
Henkens T et al. Trichostatin A, a critical factor in maintaining the functional differentiation of primary cultured rat hepatocytes. 2007 Toxicol. Appl. Pharmacol. pmid:17125810
Yan Y et al. Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure. 2003 Toxicol. Appl. Pharmacol. pmid:12902198
Ding SZ et al. Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells. 2013 Toxicol. Appl. Pharmacol. pmid:23518002
Van Beneden K et al. Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis. 2013 Toxicol. Appl. Pharmacol. pmid:23707763
Weng YI et al. Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. 2010 Toxicol. Appl. Pharmacol. pmid:20678512
Li X et al. Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis. 2016 Toxicol. Appl. Pharmacol. pmid:27396813
Di Renzo F et al. Boric acid inhibits embryonic histone deacetylases: a suggested mechanism to explain boric acid-related teratogenicity. 2007 Toxicol. Appl. Pharmacol. pmid:17320131
Wu TC et al. The enhancing effect of genistein on apoptosis induced by trichostatin A in lung cancer cells with wild type p53 genes is associated with upregulation of histone acetyltransferase. 2016 Toxicol. Appl. Pharmacol. pmid:26768552
Busbee PB et al. Natural indoles, indole-3-carbinol and 3,3'-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression. 2014 Toxicol. Appl. Pharmacol. pmid:24200994
Zhang Z et al. Role of histone acetylation in activation of nuclear factor erythroid 2-related factor 2/heme oxygenase 1 pathway by manganese chloride. 2017 Toxicol. Appl. Pharmacol. pmid:29054681
Yan YE et al. Prenatal nicotinic exposure suppresses fetal adrenal steroidogenesis via steroidogenic factor 1 (SF-1) deacetylation. 2014 Toxicol. Appl. Pharmacol. pmid:24709674
Cheng X et al. Generation and characterization of gsuα:EGFP transgenic zebrafish for evaluating endocrine-disrupting effects. 2014 Toxicol. Appl. Pharmacol. pmid:24747804
Zhang Q et al. Inhibition and reversal of nickel-induced transformation by the histone deacetylase inhibitor trichostatin A. 2003 Toxicol. Appl. Pharmacol. pmid:14575637
Yeh BW et al. Histone deacetylase inhibitor trichostatin A resensitizes gemcitabine resistant urothelial carcinoma cells via suppression of TG-interacting factor. 2016 Toxicol. Appl. Pharmacol. pmid:26589485
Chen J et al. Prevention of cytotoxicity of nickel by quercetin: the role of reactive oxygen species and histone acetylation. 2013 Toxicol Ind Health pmid:22294440
Bolleyn J et al. Effect of Trichostatin A on miRNA expression in cultures of primary rat hepatocytes. 2011 Toxicol In Vitro pmid:21513791
Kang J et al. Antioxidants and trichostatin A synergistically protect against in vitro cytotoxicity of Ni2+ in human hepatoma cells. 2005 Toxicol In Vitro pmid:15649630
Sancak D and Ozden S Global histone modifications in Fumonisin B1 exposure in rat kidney epithelial cells. 2015 Toxicol In Vitro pmid:26208285
de Boer J et al. Inhibition of histone acetylation as a tool in bone tissue engineering. 2006 Tissue Eng. pmid:17518660
Jin H et al. HDAC inhibitor trichostatin A promotes proliferation and odontoblast differentiation of human dental pulp stem cells. 2013 Tissue Eng Part A pmid:23013422
Dom G et al. 5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro. 2013 Thyroid pmid:23167291
Greenberg VL et al. Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells. 2001 Thyroid pmid:11349829
Gao S et al. CpG methylation of the PAI-1 gene 5'-flanking region is inversely correlated with PAI-1 mRNA levels in human cell lines. 2005 Thromb. Haemost. pmid:16268485
Toki S et al. The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation. 2016 Thorax pmid:27071418
Cervera RP et al. Trichostatin A affects histone acetylation and gene expression in porcine somatic cell nucleus transfer embryos. 2009 Theriogenology pmid:19765811
Chen CH et al. Synergistic effect of trichostatin A and scriptaid on the development of cloned rabbit embryos. 2013 Theriogenology pmid:23566670
Saini M et al. Trichostatin A alters the expression of cell cycle controlling genes and microRNAs in donor cells and subsequently improves the yield and quality of cloned bovine embryos in vitro. 2014 Theriogenology pmid:25151601
Luo C et al. Treatment of donor cells with trichostatin A improves in vitro development and reprogramming of buffalo (Bubalus bubalis) nucleus transfer embryos. 2013 Theriogenology pmid:24007823
Shao GB et al. Effect of trychostatin A treatment on gene expression in cloned mouse embryos. 2009 Theriogenology pmid:19246084
Opiela J et al. In vitro development and cytological quality of inter-species (porcine→bovine) cloned embryos are affected by trichostatin A-dependent epigenomic modulation of adult mesenchymal stem cells. 2017 Theriogenology pmid:28583605
Ding X et al. Increased pre-implantation development of cloned bovine embryos treated with 5-aza-2'-deoxycytidine and trichostatin A. 2008 Theriogenology pmid:18556056
Ji Q et al. Improvement of porcine cloning efficiency by trichostain A through early-stage induction of embryo apoptosis. 2013 Theriogenology pmid:23347745